30 results on '"Ruiz, Lidia"'
Search Results
2. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA
3. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen
4. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients
5. Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen
6. Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide
7. The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy
8. Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load
9. Virological rebound after suppression on highly active antiretroviral therapy
10. Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine
11. Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity
12. Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions
13. Clinical utility of HIV-1 genotyping and expert advice: the Havana trial
14. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain
15. Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads
16. HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
17. Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain
18. Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir
19. Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression
20. Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen
21. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication
22. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients
23. Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy
24. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
25. The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy
26. Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries
27. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain
28. Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC
29. Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)
30. Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300×106/l
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.